TAGLIALATELA, MAURIZIO
 Distribuzione geografica
Continente #
AS - Asia 5.827
EU - Europa 4.544
NA - Nord America 4.294
SA - Sud America 1.068
AF - Africa 133
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 15.873
Nazione #
US - Stati Uniti d'America 4.016
SG - Singapore 3.296
RU - Federazione Russa 2.242
CN - Cina 1.065
IT - Italia 912
BR - Brasile 862
HK - Hong Kong 604
VN - Vietnam 489
DE - Germania 260
FI - Finlandia 233
NL - Olanda 183
CA - Canada 180
GB - Regno Unito 128
UA - Ucraina 124
IE - Irlanda 104
AR - Argentina 90
FR - Francia 75
MX - Messico 67
IN - India 65
SE - Svezia 64
PL - Polonia 58
AT - Austria 43
BD - Bangladesh 38
KR - Corea 37
ID - Indonesia 36
JP - Giappone 33
EC - Ecuador 32
ZA - Sudafrica 32
ES - Italia 26
TR - Turchia 22
CO - Colombia 20
CI - Costa d'Avorio 19
IQ - Iraq 19
PY - Paraguay 19
VE - Venezuela 15
BE - Belgio 14
EG - Egitto 14
IL - Israele 12
MA - Marocco 11
PK - Pakistan 11
AZ - Azerbaigian 10
GR - Grecia 10
UZ - Uzbekistan 10
CL - Cile 9
DZ - Algeria 9
LB - Libano 9
OM - Oman 9
RS - Serbia 9
SA - Arabia Saudita 9
UY - Uruguay 9
BG - Bulgaria 7
IS - Islanda 7
PE - Perù 7
JM - Giamaica 6
BW - Botswana 5
CZ - Repubblica Ceca 5
IR - Iran 5
JO - Giordania 5
LT - Lituania 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
BY - Bielorussia 4
CH - Svizzera 4
GH - Ghana 4
KE - Kenya 4
KZ - Kazakistan 4
NP - Nepal 4
PT - Portogallo 4
CR - Costa Rica 3
CY - Cipro 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
HU - Ungheria 3
KG - Kirghizistan 3
MD - Moldavia 3
ML - Mali 3
NI - Nicaragua 3
PS - Palestinian Territory 3
TN - Tunisia 3
AF - Afghanistan, Repubblica islamica di 2
AO - Angola 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BZ - Belize 2
CG - Congo 2
EE - Estonia 2
EU - Europa 2
GE - Georgia 2
GT - Guatemala 2
GY - Guiana 2
LC - Santa Lucia 2
LK - Sri Lanka 2
MG - Madagascar 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PA - Panama 2
PR - Porto Rico 2
Totale 15.830
Città #
Singapore 1.474
Hong Kong 600
Moscow 567
Chandler 384
Ashburn 326
Beijing 308
Millbury 265
Hefei 218
Naples 206
Princeton 187
Santa Clara 178
Jacksonville 157
Los Angeles 152
Ho Chi Minh City 148
Amsterdam 132
Ottawa 120
Dallas 108
Nanjing 103
Dong Ket 93
Buffalo 86
Redondo Beach 85
Des Moines 83
Boston 76
Hanoi 76
São Paulo 76
Napoli 75
Munich 60
Wilmington 58
Seattle 54
New York 53
Milan 50
The Dalles 50
Nanchang 37
Marano di Napoli 35
Seoul 35
Warsaw 34
Formia 33
Norwalk 33
Houston 32
Mexico City 30
Shenyang 30
Nuremberg 28
Chicago 26
Haiphong 26
Lawrence 26
Montreal 26
Turku 24
Guangzhou 23
Hebei 23
Johannesburg 23
Atlanta 22
Brasília 22
Tianjin 22
Belo Horizonte 21
Frankfurt am Main 21
Orem 21
Brooklyn 20
Tokyo 19
Washington 19
London 18
Vienna 18
Dublin 17
Phoenix 17
Breda 16
Chennai 16
Helsinki 16
Jiaxing 16
Stockholm 16
Trentola-Ducenta 16
Gdansk 15
Poplar 15
Changsha 14
Curitiba 14
Denver 14
Falkenstein 14
Verona 14
Falls Church 13
Lappeenranta 13
Rio de Janeiro 13
Toronto 13
Vancouver 13
Biên Hòa 12
Campinas 12
Da Nang 12
Charlotte 11
Kunming 11
Manchester 11
Rome 11
Boardman 10
Joinville 10
Quito 10
Salvador 10
Ann Arbor 9
Guayaquil 9
Hải Dương 9
Jakarta 9
Jordanstown 9
Montevideo 9
San Francisco 9
Tashkent 9
Totale 7.842
Nome #
A novel hyperekplexia-causing mutation in the pre-trasmembrane segm 1 of the human glycine receptor alpha 1 subunit reduces membrane expression and impairs gating by agonists 154
Kv7 channel activation reduces brain endothelial cell permeability and prevents kainic acid-induced blood-brain barrier damage 153
“One Health” Approach for Health Innovation and Active Aging in Campania (Italy) 133
Beyond Retigabine: Design, Synthesis, and Pharmacological Characterization of a Potent and Chemically Stable Neuronal Kv7 Channel Activator with Anticonvulsant Activity 132
Decreased subunit stability as a novel mechanism for potassium current impairment by a KCNQ2 C terminus mutation causing benign familial neonatal convulsions 129
Tryptamine-based derivatives as Transient Receptor Potential Melastatin type-8 (TRPM8) channel modulators 125
Caratterizzazione biochimica e funzionale in oociti di Xenopus Laevis e cellule CHO (Chinese Hamster Ovary Cells) di mutazioni nel gene Kcnq2 riscontrate in famiglie affette da convulsioni benigne neonatali 125
A micro-bioimpedance meter for monitoring insulin bioavailability in personalized diabetes therapy 125
Differential expression of the Na+-Ca2+ exchanger transcripts and proteins in rat brain regions. 123
Involvement of KCNQ2 subunits in [3H]dopamine release triggered by depolarization and pre-synaptic muscarinic receptor activation from rat striatal synaptosomes. 122
Decreased Subunit Stability as a Novel Mechanismfor PotassiumCurrent Impairment by a KCNQ2 C Terminus Mutation Causing Benign Familial Neonatal Convulsions 119
Generation of an iPSC line (UNINAi001-A) from a girl with neonatal-onset epilepsy and non-syndromic intellectual disability carrying the homozygous KCNQ3 p.PHE534ILEfs*15 variant and of an iPSC line (UNINAi002-A) from a non-carrier, unaffected brother 118
Insights into the pathogenesis of ATP1A1-related CMT disease using patient-specific iPSCs 114
Expression pattern of the ether-a-gogo-related (ERG) k+ channel-encoding genes ERG1, ERG2, and ERG3 in the adult rat central nervous system 113
GAIN-OF-FUNCTION DUE TO INCREASED OPENING PROBABILITY BY TWO KCNQ5 PORE VARIANTS CAUSING DEVELOPMENTAL AND/OR EPILEPTIC ENCEPHALOPATHY 112
Pure uptake blockers of dopamine can reduce prolactin secretion: studies with diclofensine 111
A novel KCNQ3 mutation in familial epilepsy with focal seizures and intellectual disability 111
Early-onset epileptic encephalopathy caused by gain-of-function mutations in the voltage sensor of Kv7.2 and Kv7.3 potassium channel subunits 111
Cardiac ion channels and antihistamines: possible mechanisms of cardiotoxicity. 110
A novel KCNQ2 K+ channel mutation in benign neonatal convulsions and centrotemporal spikes 110
Differential expression of the Na+-Ca2+ exchanger transcripts and proteins in rat brain regions 109
Differential Vulnerability of Cortical and Cerebellar Neurons in Primary Culture to Oxygen Glucose Deprivation followed by Reoxygenation. 108
Effects of manidipine and nitrendipine enantiomers on the plateau phase of K+-induced intracellular Ca2+ increase in GH3 cells. 108
Lysinuric protein intolerance: identification and functional analysis of mutations of the SLC7A7 gene. 108
A novel homozygous KCNQ3 loss-of-function variant causes non-syndromic intellectual disability and neonatal-onset pharmacodependent epilepsy 108
Synthesis and Pharmacological Characterization of Conformationally Restricted Retigabine Analogues as Novel Neuronal Kv7 Channel Activators 108
M Channels Containing KCNQ2 Subunits Modulate Norepinephrine, Aspartate, and GABA Release from Hippocampal Nerve Terminals 107
The voltage-sensing domain of Kv7.2 channels as a molecular target for epilepsy-causing mutations and anticonvulsants 107
Autism and developmental disability caused by KCNQ3 gain-of-function variants 106
A y(+)LAT-1 mutant protein interferes with y(+)LAT-2 activity: implications for the molecular pathogenesis of lysinuric protein intolerance. 104
Neuronal potassium channel openers in the management of epilepsy: Role and potential of retigabine 104
KCNQ2 R144 variants cause neurodevelopmental disability with language impairment and autistic features without neonatal seizures through a gain-of-function mechanism 103
Inhibition of depolarization-induced [3H]noradrenaline release from SH-SY5Y human neuroblastoma cells by some second-generation H(1) receptor antagonists through blockade of store-operated Ca(2+) channels (SOCs). 102
Driving with no brakes: Molecular pathophysiology of Kv7 potassium channels 102
A novel mutation in KCNQ2 associated to BFNC, drug resistant epilepsy and mental retardation 101
Retigabine and flupirtine exert neuroprotective actions in organotypic hippocampal cultures 101
Regulation of the human ether-a-gogo related gene (HERG) K+ channels by reactive oxygen species 101
Addressing the use of PDIF-CN2 molecules in the development of n-type organic field-effect transistors for biosensing applications 100
Up-regulation and increased activity of KV3.4 channels and their accessory subunit MinK-related peptide 2 induced by amyloid peptide are involved in apoptotic neuronal death 99
Molecular pathophysiology and pharmacology of the voltage-sensing module of neuronal ion channels 99
Expression pattern of the ether-a-gogo-related (ERG) K+ channel-encoding genes ERG1, ERG2, and ERG3 in the adult rat central nervous system. 97
Coupling between the voltage-sensing and phosphatase domains of Ci-VSP 97
Non-invasive real-time in-vivo monitoring of insulin absorption from subcutaneous tissues 97
Identification of Drugs Acting as Perpetrators in Common Drug Interactions in a Cohort of Geriatric Patients from Southern Italy and Analysis of the Gene Polymorphisms That Affect Their Interacting Potential 96
Expression, Localization, and Pharmacological Role of Kv7 Potassium Channels in Skeletal Muscle Proliferation, Differentiation, and Survival after Myotoxic Insults 96
Genotype-phenotype correlations in neonatal epilepsies caused by mutations in the voltage sensor of Kv7.2 potassium channel subunits 96
Genotype-phenotype correlations in patients with de novo KCNQ2 pathogenic variants 96
Atypical gating of M-type potassium channels conferred by mutations in uncharged residues in the S4 region of KCNQ2 causing benign familial neonatal convulsions 95
Activation of pre-synaptic M-type K+ channels inhibits [3H]D-aspartate release by reducing Ca2+ entry through P/Q-type voltage-gated Ca2+ channels 95
Specification of skeletal muscle differentiation by repressor element-1 silencing transcription factor (REST)-regulated Kv7.4 potassium channels 95
Epileptic channelopathies caused by neuronal Kv7 (KCNQ) channel dysfunction 94
Pharmacological Targeting Of Neuronal Kv7.2/3 Channels: A Focus On Chemotypes And Receptor Sites 93
Brain distribution of the Na+/Ca2+ exchanger-encoding genes NCX1, NCX2, and NCX3 and their related proteins in the central nervous system 92
KCNT2-related disorders: phenotypes, functional and pharmacological properties 90
Human ether-a-gogo related gene (HERG) K+ channels as pharmacological targets: present and future implications 90
Modulation of ion channels by reactive oxygen and nitrogen species: a pathophysiological role in brain aging? 90
Benign familial neonatal convulsions caused by altered gating of KCNQ2/KCNQ3 potassium channels 90
Human neoplastic mesothelial cells express voltage-gated sodium channels involved in cell motility 89
IgG Autoantibodies Against IgE from Atopic Dermatitis Can Induce the Release of Cytokines and Proinflammatory Mediators from Basophils and Mast Cells 89
Plasma prolactin levels in the inferior petrosal sinuses in various pituitary disorders during perihypophyseal phlebography 88
Molecular basis for the lack of HERG K+ channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second-generation antihistamines 88
Histidines 578 and 587 in the S5-S6 linker of the human Ether-a-gogo Related Gene-1 K+ channels confer sensitivity to reactive oxygen species 87
Functional analysis of novel KCNQ2 and KCNQ3 gene variants found in a large pedigree with benign familial neonatal convulsions (BFNC) 87
Gender-related issues in the pharmacology of new anti-obesity drugs 87
Paracetamol and ibuprofen fixed-dose combination for the management of acute mild-to-moderate pain in children: strengthening and enhancing of result of Nominal Group Technique through Delphi consensus 86
Epidemiological and Immune Profile Analysis of Italian Subjects with Endometriosis and Multiple Sclerosis 86
Pharmacological blockade of ERG K+ channels and Ca2+ influx through store-operated channels exerts opposite effects on intracellular Ca2+ oscillations in pituitary GH3 cells 86
K(V)7 channels regulate muscle tone and nonadrenergic noncholinergic relaxation of the rat gastric fund 86
A Novel Kv7.3 Variant in the Voltage-Sensing S4 Segment in a Family With Benign Neonatal Epilepsy: Functional Characterization and in vitro Rescue by β-Hydroxybutyrate 86
A new Italian FHM2 family: Clinical aspects and functional analysis of the disease-associated mutation 85
Critical role of large-conductance calcium- and voltage-activated potassium channels in leptin-induced neuroprotection of N-methyl-d-aspartate-exposed cortical neurons 85
Blockade of herg K+ channels by second-generation H1 receptor-antagonists may regulate [Ca2+]i oscillations in GH3 cells 84
Gating currents from Kv7 channels carrying neuronal hyperexcitability mutations in the voltage-sensing domain 84
Molecular basis for the cardiovascular adverse effects of the first- and second-generation antihistamines. 82
Gating consequences of charge neutralization of arginine residues in the S4 segment of K(v)7.2, an epilepsy-linked K+ channel subunit 81
Histamine induces exocytosis and IL-6 production from human lung macrophages through interaction with H1 receptors 81
Early treatment with quinidine in two patients with epilepsy of infancy with migrating focal seizures (EIMFS) due to gain-of-function KCNT1 mutations: functional studies, clinical responses and critical issues for personalized therapy 81
Kv7.4 channels regulate potassium permeability in neuronal mitochondria 81
A pharmacological study on the possible mechanisms underlying changes in TSH secretion in aged male rats 80
Prolonged exposure of pituitary dopaminergic receptors to the phospholipid phosphatidylserine increases their sensitivity to dopamine in aged rats 80
Gating currents from neuronal KV7.4 Channels: General features and correlation with the ionic conductance 80
New advances in beta-blocker therapy in heart failure 79
KCNQ3 is the principal target of retigabine in CA1 and subicular excitatory neurons 79
Potassium current inactivation as a novel pathomechanism for KCNQ2 developmental and epileptic encephalopathy 78
Vasorelaxation by hydrogen sulphide involves activation of Kv7 potassium channels 78
Neurobiology of coronaviruses: Potential relevance for COVID-19 78
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine 77
Domperidone antagonizes bromoergocriptine--induced nausea and vomiting without affecting its inhibition of prolactin secretion in puerperal women. 76
Pre-synaptic BK channels selectively control glutamate versus GABA release from cortical and hippocampal nerve terminals 76
Distinct epilepsy phenotypes and response to drugs in KCNA1 gain- and loss-of function variants 76
Inhibition of depolarization-induced [3H]noradrenaline release from SH-SY5Y human neuroblastoma cells by some second-generation H(1) receptor antagonists through blockade of store-operated Ca(2+) channels (SOCs). 75
Manidipine and Nitrendipine R and S enantiomers block voltage-gated Ca2+ channel (VGCC) with different kinetic in GH3 cell 75
Early-onset epileptic encephalopathy caused by a reduced sensitivity of Kv7.2 potassium channels to phosphatidylinositol 4,5-bisphosphate 74
Activation of Kv7 potassium channels inhibits intracellular Ca2+ increases triggered by TRPV1-mediated pain-inducing stimuli in F11 immortalized sensory neurons 74
Protein-tyrosine kinases activate while protein-tyrosine phosphatases inhibit L-type calcium channel activity in pituitary GH3 cells. 73
Molecular and pharmacological evidence for a facilitatory functional role of pre-synaptic GLUK2/3 kainate receptors on GABA release in rat trigeminal caudal nucleus 73
Cardiac ion channels and antihistamines: possible mechanisms of cardiotoxicity 73
Cobalt-sensitive and dihydropyridine-insensitive stimulation of dopamine release from tuberoinfundibular neurons by high extracellular concentrations of barium ions 72
Epilepsy phenotype and response to KCNQ openers in mice harboring the Kcnq2 R207W voltage-sensor mutation 71
De novo variants in KCNA3 cause developmental and epileptic encephalopathy 71
Totale 9.591
Categoria #
all - tutte 56.005
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.005


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021343 0 0 0 0 0 78 38 33 39 16 44 95
2021/20221.029 14 7 5 14 15 33 10 38 120 62 213 498
2022/20231.166 229 118 21 148 135 98 8 73 150 132 44 10
2023/2024826 40 93 97 52 60 79 22 71 19 17 189 87
2024/20255.430 306 359 27 50 104 215 726 339 432 531 1.749 592
2025/20265.892 1.123 808 1.166 953 1.545 297 0 0 0 0 0 0
Totale 16.216